News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

PRANA Biotechnology (PRAN) Announces PNAS Publication Describing New Class of Anti-Amyloid Drugs


5/13/2008 11:33:31 AM

MELBOURNE, AUSTRALIA--(Marketwire - May 13, 2008) - Prana Biotechnology Limited (NASDAQ: PRAN) (ASX: PBT), a biopharmaceutical company focused on the research and development of treatments for neurodegenerative disorders, today announced a publication in the Proceedings of the National Academy of Sciences (PNAS) journal,(1) describing a completely new class of amyloid inhibiting drugs.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES